Trial Profile
Phase 1 Study of Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan(R) Tablet 5/50 mg
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jun 2015
Price :
$35
*
At a glance
- Drugs Amlodipine/losartan (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Korea United Pharm Inc
- 11 Jun 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jun 2014 New trial record